Eagle Health Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8M | Hold |
627,600
| – | – | 5.63% | 8 |
|
|
2025
Q1 | $22.7M | Hold |
627,600
| – | – | 5.9% | 9 |
|
|
2024
Q4 | $26.4M | Buy |
627,600
+65,900
| +12% | +$2.77M | 6.47% | 7 |
|
|
2024
Q3 | $31.2M | Buy |
561,700
+37,200
| +7% | +$2.07M | 5.91% | 7 |
|
|
2024
Q2 | $21.6M | Buy |
524,500
+224,800
| +75% | +$9.24M | 3.78% | 11 |
|
|
2024
Q1 | $14M | Buy |
+299,700
| New | +$14M | 2.6% | 15 |
|